India’s first minimally invasive- Robotic Hybrid Revascularisation performed at Apollo Hospitals, Chennai
India’s first minimally invasive- Robotic Hybrid Revascularisation
performed at Apollo Hospitals, Chennai
Chennai:
Apollo
Hospitals, Asia’s largest and most trusted multi-specialty chain of hospitals
became the first centre in India to perform minimally invasive- Robotic Hybrid
Revascularisation surgery to treat blocks in two major blood vessels to improve
blood flow to the heart. The cutting-edge procedure gave a new lease of life to
a63 year old femalepatient from Chennai.
Robotic Minimally Invasive Hybrid
Revascularisation is a procedure that combines minimally invasive coronary
artery bypass grafting surgery (CABG) and angiography stenting procedure with
Robotic assistance to achieve precision while treating patients with multi
vessel coronary artery disease.
Mrs. J. Malliga,63 year old lady from
Ambattur(Chennai) was brought to Apollo Hospitals Chennai on 18th
February,2018with worsening chest pain that was persistent over 6 months. It
was identified that she had blocks in two of the major blood vessels that
supply blood to the heart. Patients with such severe blockage are mostly
treated with a conventional Bypass surgery (by splitting the central chest
bone) which is an intense procedure that needs a longer recovery time
post-surgery which is over three to four months.
Dr. M
M. Yusuf - Cardiothoracic surgeon specialising in Minimally Invasive Cardiac
Surgery, Apollo Hospitals and his team decided to use a minimally invasive
technique rather than the traditional approach on the patient. This minimally
invasive-Hybrid Revascularisation procedure with Robotic assistanceallows the
surgeon to work on a beating heart through a small chest incision (small
thoracotomy) without having to split the chest bone.
Dr. M M. Yusufand team performed this procedure
with a unique two stage approach using Robotic assistance. Two of the three
major blood vessel of the patient was severely blocked reducing the heart
function completely. She also had blocks in other vessels, which could be
treated either with surgery or angiography stent insertion.As the patient was a
not convinced with a conventional bypass, Dr Yusuf performed the Minimally
Invasive CABG using a robot under the guidance of Dr Frank Vanpraet, Director of Robotic and Minimally Invasive cardiac
surgery, OLV Hospital, Aalst, Belgium.This procedure helped quick recovery
and major morbidity.
Describing the procedureDr. M M. Yusuf -
Cardiothoracic surgeon specialising in Minimally Invasive Cardiac Surgery,
Apollo Hospitalssaid,“In the thoracotomy -beating heart approach, the surgeon
can perform the operation through a tiny incision under the left nipple (four
or five centimetres wide) while the heart continues to beat. This technique
lowers the risk of complications that arises if a conventional
bypass method is used. The patients have reduced pain and less need for
postoperative pain medication, smaller scars, a shorter stay in the hospital
and a faster recovery.”
He added, “As a stage two approach the
patientunderwent Angiography and Drug Eluting Stent insertion to the remaining blockages
in the coronary artery under specialised Intravascular Ultrasound Guidance. This
was performed by Dr.Damodharan, Senior
Consultant Cardiologist, Apollo Hospitals,Chennai. The patient had
excellent results in the check angiography after stent insertion and surgery.This
patient was very cooperative and recovered in 48 hours and was discharged.”
Robotic assisted CABG is the least invasive
method of minimally invasive cardiac surgery. Blood loss, pain are negligible
and it reduces hospital stay with extremely quick recovery. This procedure
would be suitable to treat many patients with multi-vessel vessel coronary
artery disease. Patients can return back to full normal activity with 2 weeks.
Dr. Mohammad Yusuf and team had earlier in
March 2018 performed India’s first Minimally Invasive Hybrid Revascularisation procedure (without Robotic
assistance) on a 53 year old man saving him from a triple vessel blocks.
ABOUT APOLLO HOSPITALS
It was in 1983, that Dr. Prathap Reddy made
a pioneering endeavour by launching India’s first corporate hospital - Apollo
Hospitals in Chennai. Over the years Apollo Hospitals has established itself as
home to the largest cardiac practice in India with over 160,000 cardiac
surgeries. Apollo Hospitals is also the world’s largest private cancer care
provider and runs the world’s leading solid organ transplant program.
As Asia’s largest and most trusted
healthcare group, its presence includes 9,215 beds across 64 Hospitals, 2,500
Pharmacies, over 90 Primary Care and Diagnostic Clinics, 110 plus Telemedicine Centres and 80 plus Apollo
Munich Insurance branches spanning the
length and breadth of the Country.
As an integrated healthcare service provider
with Health Insurance services, Global Projects Consultancy capability, over 15
medical education centres and a Research Foundation with a focus on global
Clinical Trials, epidemiological studies, stem cell & genetic research
Apollo Hospitals has been at the forefront of new medical breakthroughs with
the most recent investment being that of commissioning the first Proton Therapy
Center across Asia, Africa and Australia in Chennai, India. Every four days,
the Apollo Hospitals Group touches a million lives, in its mission to bring
healthcare of International standards within the reach of every individual.
In a rare honour, the Government of India
issued a commemorative stamp in recognition of Apollo's contribution, the first
for a healthcare organization. Apollo Hospitals Chairman, Dr. Prathap C Reddy,
was conferred with the prestigious Padma Vibhushan in 2010. For more than 30
years, the Apollo Hospitals Group has continuously excelled and maintained
leadership in medical innovation, world-class clinical services and
cutting-edge technology. Our hospitals are consistently ranked amongst the best
hospitals globally for advanced medical services and research.